RAC1 and cardiac hypertrophy: Therefore, inhibition of Rac1 signaling by enhanced RGS3L expression is a potential cardioprotective therapeutic strategy in cardiac hypertrophy, fibrosis, arrhythmias, and heart failure [3, 20].